Cuproptosis in glioma: mechanisms, biological roles and therapeutic perspectives
- 1Department of Neurosurgery, The Second Hospital of Hebei Medical University
Abstract
Glioma is the primary malignant tumor with the highest incidence rate in the central nervous system of adults. Its recurrence and drug resistance need to be solved urgently. The newly discovered cuproptosis in 2022, as a copper-dependent cell death mode, triggers protein toxicity stress by targeting acylated proteins in the mitochondrial respiratory chain, providing novel insights into potential therapeutic vulnerabilities in glioma. This article systematically reviews the mechanism of cuproptosis homeostasis regulation, the dual role of copper in glioma proliferation, angiogenesis, invasion and migration, drug resistance, and immune microenvironment, and focuses on the research progress of cuproptosis inducers, copper chelators, and cuproptosis-based nanomedicines in glioma treatment. We further summarize current bioinformatics studies investigating cuproptosis-related genes in glioma, highlighting their potential value in prognosis prediction, immune infiltration, and molecular classification. Although the mechanisms and clinical applications of cuproptosis require further investigation, its combination with nanotechnology and immunotherapy offers promising avenues for future glioma treatment.
Related
- Ferroptosis and Cuproptosis in the Pathogenesis of Breast Cancer: Molecular Mechanisms, Crosstalk, and Therapeutic Perspectives
- MiR-532 as a Potential Therapeutic Target and Biomarker: Biological Functions, Molecular Mechanisms, and Clinical Perspectives.
- Magnesium in Skin Aging, Wound Healing, and Some Specific Dermatologic Disorders: A Narrative Review on Biological Mechanisms, Clinical Evidence, and Therapeutic Perspectives
- Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
- Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
BibTeX
@article{cui2026cuproptosis,
title = {{Cuproptosis in glioma: mechanisms, biological roles and therapeutic perspectives}},
author = {Hairui Cui and Sai Li and Zhijian Li and Xiangrong Zhang and Jiankai Yang},
journal = {Discover Oncology},
year = {2026},
month = jul,
doi = {10.1007/s12672-026-05639-0},
url = {https://doi.org/10.1007/s12672-026-05639-0},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cuproptosis in glioma: mechanisms, biological roles and therapeutic perspectives
AU - Hairui Cui
AU - Sai Li
AU - Zhijian Li
AU - Xiangrong Zhang
AU - Jiankai Yang
PY - 2026
DA - 2026/07/01
JO - Discover Oncology
DO - 10.1007/s12672-026-05639-0
UR - https://doi.org/10.1007/s12672-026-05639-0
AB - Glioma is the primary malignant tumor with the highest incidence rate in the central nervous system of adults. Its recurrence and drug resistance need to be solved urgently. The newly discovered cuproptosis in 2022, as a copper-dependent cell death mode, triggers protein toxicity stress by targeting acylated proteins in the mitochondrial respiratory chain, providing novel insights into potential therapeutic vulnerabilities in glioma. This article systematically reviews the mechanism of cuproptosis homeostasis regulation, the dual role of copper in glioma proliferation, angiogenesis, invasion and migration, drug resistance, and immune microenvironment, and focuses on the research progress of cuproptosis inducers, copper chelators, and cuproptosis-based nanomedicines in glioma treatment. We further summarize current bioinformatics studies investigating cuproptosis-related genes in glioma, highlighting their potential value in prognosis prediction, immune infiltration, and molecular classification. Although the mechanisms and clinical applications of cuproptosis require further investigation, its combination with nanotechnology and immunotherapy offers promising avenues for future glioma treatment.
SN - 2730-6011
ER -